Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1977 2
1980 2
1982 1
1983 1
1984 3
1985 1
1986 2
1987 5
1988 3
1989 1
1990 4
1992 2
1993 2
1994 3
1995 3
1996 2
1997 5
1998 1
1999 5
2000 3
2001 2
2003 5
2004 2
2005 6
2006 6
2007 6
2008 7
2009 8
2010 4
2011 4
2012 6
2013 10
2014 9
2015 10
2016 4
2017 5
2018 5
2019 5
2020 7
2021 7
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis.
Nelson AD, Camilleri M, Chirapongsathorn S, Vijayvargiya P, Valentin N, Shin A, Erwin PJ, Wang Z, Murad MH. Nelson AD, et al. Gut. 2017 Sep;66(9):1611-1622. doi: 10.1136/gutjnl-2016-311835. Epub 2016 Jun 10. Gut. 2017. PMID: 27287486 Free article. Review.
Bisacodyl, NaP, prucalopride and velusetrag were superior to placebo for the 3 CSBM/week end point. ...CONCLUSIONS: Current drugs for CIC show similar efficacy. Bisacodyl may be superior to prescription medications for delta(b) in the number of SBM/week in CIC....
Bisacodyl, NaP, prucalopride and velusetrag were superior to placebo for the 3 CSBM/week end point. ...CONCLUSIONS: Current drugs for
Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
Luthra P, Camilleri M, Burr NE, Quigley EMM, Black CJ, Ford AC. Luthra P, et al. Lancet Gastroenterol Hepatol. 2019 Nov;4(11):831-844. doi: 10.1016/S2468-1253(19)30246-8. Epub 2019 Aug 29. Lancet Gastroenterol Hepatol. 2019. PMID: 31474542 Free article.
Based on an endpoint of failure to achieve three or more complete spontaneous bowel movements (CSBMs) per week, the stimulant diphenyl methane laxatives bisacodyl and sodium picosulfate, at a dose of 10 mg once daily, were ranked first at 4 weeks (RR 0.55, 95% CI 0.48-0.63 …
Based on an endpoint of failure to achieve three or more complete spontaneous bowel movements (CSBMs) per week, the stimulant diphenyl metha …
Comparison of efficacies of vegetable oil based and polyethylene glycol based bisacodyl suppositories in treating patients with neurogenic bowel dysfunction after spinal cord injury: a meta-analysis.
Yi Z, Jie C, Wenyi Z, Bin X, Hongzhu J. Yi Z, et al. Turk J Gastroenterol. 2014 Oct;25(5):488-92. doi: 10.5152/tjg.2014.6708. Turk J Gastroenterol. 2014. PMID: 25417608 Free article. Review.
BACKGROUND/AIMS: We performed a meta-analysis to compare the efficacies of vegetable oil based bisacodyl (VOB) and polyethylene glycol based bisacodyl (PGB) suppositories in treating patients with neurogenic bowel dysfunction (NBD) after spinal cord injury (SCI). .. …
BACKGROUND/AIMS: We performed a meta-analysis to compare the efficacies of vegetable oil based bisacodyl (VOB) and polyethylene glyco …
Oral bisacodyl is effective and well-tolerated in patients with chronic constipation.
Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U. Kamm MA, et al. Clin Gastroenterol Hepatol. 2011 Jul;9(7):577-83. doi: 10.1016/j.cgh.2011.03.026. Epub 2011 Mar 25. Clin Gastroenterol Hepatol. 2011. PMID: 21440672 Clinical Trial.
We tested the efficacy and safety of 4 weeks of treatment with oral bisacodyl tablets in patients with chronic constipation, defined by Rome III criteria. ...Treatment with bisacodyl was well-tolerated. CONCLUSIONS: Oral bisacodyl is an effective and well-tol …
We tested the efficacy and safety of 4 weeks of treatment with oral bisacodyl tablets in patients with chronic constipation, defined …
Combination of bisacodyl suppository and 1 L polyethylene glycol plus ascorbic acid is a non-inferior and comfortable regimen compared to 2 L polyethylene glycol plus ascorbic acid.
Kim SH, Kim ER, Kim K, Kim TJ, Hong SN, Chang DK, Kim YH. Kim SH, et al. Dig Endosc. 2020 May;32(4):600-607. doi: 10.1111/den.13548. Epub 2019 Nov 11. Dig Endosc. 2020. PMID: 31574170 Clinical Trial.
The primary aim of the present study was to compare the efficacy of bowel cleansing between 2 L PEG-Asc (control) and 1 L PEG-Asc with bisacodyl suppository (suppository) groups, and the secondary aim was to investigate complications and tolerability between the two groups …
The primary aim of the present study was to compare the efficacy of bowel cleansing between 2 L PEG-Asc (control) and 1 L PEG-Asc with bi
High amplitude propagated contractions with Glycerin versus Bisacodyl: A within-subject comparison in children undergoing colonic manometry.
Mansi S, Bahia G, Patel D, Dorfman L, El-Chammas K, Fei L, Liu C, Santucci NR, Graham K, Kaul A. Mansi S, et al. Neurogastroenterol Motil. 2023 May;35(5):e14544. doi: 10.1111/nmo.14544. Epub 2023 Feb 27. Neurogastroenterol Motil. 2023. PMID: 37096635 Free PMC article. Clinical Trial.
HAPCs characteristics with each drug have not been compared before. We aimed to compare the HAPC characteristics with Bisacodyl and Glycerin in children undergoing CM for constipation. METHODS: This is a prospective single-center cross-over study of children aged 2-18 year …
HAPCs characteristics with each drug have not been compared before. We aimed to compare the HAPC characteristics with Bisacodyl and G …
Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation.
Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA. Kienzle-Horn S, et al. Curr Med Res Opin. 2007 Apr;23(4):691-9. doi: 10.1185/030079907x178865. Curr Med Res Opin. 2007. PMID: 17407625 Clinical Trial.
There was a trend for better tolerability in patients receiving bisacodyl treatment based on the number of drug-related adverse events (bisacodyl: 7; sodium picosulphate: 14, two patients withdrawn). CONCLUSIONS: Bisacodyl and sodium picosulphate are equally …
There was a trend for better tolerability in patients receiving bisacodyl treatment based on the number of drug-related adverse event …
Bisacodyl plus split 2-L polyethylene glycol-citrate-simethicone improves quality of bowel preparation before screening colonoscopy.
Valiante F, Bellumat A, De Bona M, De Boni M. Valiante F, et al. World J Gastroenterol. 2013 Sep 7;19(33):5493-9. doi: 10.3748/wjg.v19.i33.5493. World J Gastroenterol. 2013. PMID: 24023492 Free PMC article. Clinical Trial.
AIM: To compare the bowel cleansing efficacy, tolerability and acceptability of split 2-L polyethylene glycol (PEG)-citrate-simethicone (PEG-CS) plus bisacodyl (BIS) vs 4-L PEG for fecal occult blood test-positive screening colonoscopy. ...
AIM: To compare the bowel cleansing efficacy, tolerability and acceptability of split 2-L polyethylene glycol (PEG)-citrate-simethicone (PEG …
Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers.
Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD. Manabe N, et al. Aliment Pharmacol Ther. 2009 Nov 1;30(9):930-6. doi: 10.1111/j.1365-2036.2009.04118.x. Epub 2009 Aug 12. Aliment Pharmacol Ther. 2009. PMID: 19678812 Free PMC article. Clinical Trial.
BACKGROUND: The mechanism of action of bisacodyl in the unprepared human colon remains unclear. AIM: To evaluate the effect of oral bisacodyl on the overall and regional colonic transit in humans. ...Numerical differences in colonic geometric centre 24 h [bisacod
BACKGROUND: The mechanism of action of bisacodyl in the unprepared human colon remains unclear. AIM: To evaluate the effect of oral …
Magnesium citrate-bisacodyl regimen proves better than castor oil for colonoscopic preparation.
Chen CC, Ng WW, Chang FY, Lee SD. Chen CC, et al. J Gastroenterol Hepatol. 1999 Dec;14(12):1219-22. doi: 10.1046/j.1440-1746.1999.02032.x. J Gastroenterol Hepatol. 1999. PMID: 10634161 Clinical Trial.
Group 1 (n = 36) received a magnesium citrate solution (250 mL) and bisacodyl (10 mg, orally). Group 2 (n = 34) received castor oil (60 mL, orally). ...CONCLUSIONS: A combined oral magnesium citrate and bisacodyl regimen is effective and better than castor oil for c …
Group 1 (n = 36) received a magnesium citrate solution (250 mL) and bisacodyl (10 mg, orally). Group 2 (n = 34) received castor oil ( …
164 results